RT Journal Article
SR Electronic
A1 Vinall, Maria
T1 Quetiapine for the Treatment of Schizophrenia—Selected Posters
JF MD Conference Express
YR 2008
FD SAGE Publications
VO 8
IS 3
SP 14
OP 14
DO 10.1177/155989770800800309
UL http://mdc.sagepub.com/content/8/3/14.1.abstract
AB Schizophrenia accounts for a significant portion of the global burden of neuropsychiatric disorders. It is often refractory to treatment and relapse due to poor adherence is also common. In addition, treatments for schizophrenia are frequently associated with side effects that can cause serious medical problems, such as cardiovascular disease. Quetiapine is approved for the treatment of schizophrenia and impacts a broad range of symptoms that affect quality of life.